GAMBARAN PREEKLAMSIA DAN EKLAMSIA DITINJAU DARI FAKTOR RISIKO DI RSUD CIAWI
Article Sidebar
Main Article Content
Abstract
Latar belakang. Hipertensi pada kehamilan terjadi sekitar 10% ibu hamil di dunia. Kelompok hipertensi pada ibu hamil dapat dibagi menjadi tiga diantaranya; preeklamsia dan eklamsia, hipertensi gestasional, dan hipertensi kronik. Preeklamsia dan eklamsia merupakan salah satu kondisi yang paling serius karena dampak yang besar terhadap ibu dan bayi. Faktor risiko yang berperan dalam terjadinya preeklamsia dan eklamsia antara lain usia ibu, jumlah kehamilan, riwayat preeklamsia, riwayat hipertensi kronik, diabetes, riwayat keluarga, dan obesitas. Tujuan. Penelitian ini bertujuan untuk mengetahui prevalensi serta gambaran faktor risiko preeklamsia dan eklamsia di RSUD Ciawi, Bogor, Jawa Barat. Metode. Dilakukan penelitian deskriptif retrospektif menggunakan data sekunder yaitu rekam medis medis pasien preeklamsia dan eklamsia pada periode 1 Januari 2020 – 31 Desember 2021 di RSUD Ciawi. Hasil. Didapatkan jumlah pasien preeklamsia berjumlah 349 orang dan eklamsia berjumlah 25 orang. Jumlah kasus preeklamsia terbanyak didapatkan pada ibu berusia 35-40 tahun (32,4%), multigravida (75,9%) dan gizi lebih (38.2%). Mayoritas kasus preeklamsia tanpa faktor risiko. Sementara itu jumlah kasus eklamsia terbanyak didapatkan pada ibu berusia <25 tahun (2,1%), multigravida (16%) dan status gizi lebih (3,5%). Mayoritas kasus eklamsia tanpa faktor risiko. Kesimpulan Prevalensi ibu yang mengalami preeklamsia adalah 349 orang dan eklamsia 25 orang. Gambaran faktor risiko pada ibu dengan preeklamsia tertinggi terjadi di usia ibu 35-40 tahun, multigravida, dan gizi lebih. Sedangkan pada eklamsia tertinggi terjadi di usia ibu <25 tahun, multigravida, dan gizi lebih. Mayoritas kasus preeklamsia dan eklamsia tanpa faktor risiko. Penelitian ini menyarankan dilakukan penelitian lebih lanjut, dengan menilai faktor resiko sosioekonomi, riwayat komplikasi kehamilan pada preeklamsia.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under a Jurnal Muara Ilmu Ekonomi dan Bisnis Creative Commons Attribution-ShareAlike 4.0 International License.References
Abalos, E., Cuesta, C., Grosso, A. L., Chou, D., & Say, L. (2013). Global and regional estimates of preeclampsia and eclampsia: A systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology, 170(1), 1–7. https://doi.org/10.1016/j.ejogrb.2013.05.005
ACOG. (2019). ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.
Obstetrics & Gynecology, 133(1), 1–1. https://doi.org/10.1097/AOG.0000000000003018 Adegbesan-Omilabu, M. A., Okunade, K. S., Gbadegesin, A., & Akinsola, O. (2014). Risk Factors
for Pre-eclampsia in Multiparous Women in Lagos, Nigeria. International Journal of Biomedical Research, 5(4), 288. https://doi.org/10.7439/ijbr.v5i4.564
Anas, M., & Marlina, U. (2018). Penggunaan Nitrovasodilator sebagai Donor Oksida Nitrik pada Preeklamsia. 27.
Andriani, C., Lipoeto, N. I., & Indra Utama, B. (2016). Hubungan Indeks Massa Tubuh dengan Kejadian Preeklampsia di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas, 5(1). https://doi.org/10.25077/jka.v5i1.464
Bangsa, N. K., Romdoni, R., & Subagyo, S. (2021). Clinical Symptoms of Patient with Heart Failure in Dr. Soetomo General Hospital: A Descriptive Study. JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga, 12(2), 61.
https://doi.org/10.20473/juxta.V12I22021.61-65
Bartsch, E., Medcalf, K. E., Park, A. L., & Ray, J. G. (2016). Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies. BMJ, i1753. https://doi.org/10.1136/bmj.i1753
Bdolah, Y., Elchalal, U., Natanson-Yaron, S., Yechiam, H., Bdolah-Abram, T., Greenfield, C., Goldman-Wohl, D., Milwidsky, A., Rana, S., Karumanchi, S. A., Yagel, S., & Hochner- Celnikier, D. (2014). Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertension in Pregnancy, 33(2), 250–259. https://doi.org/10.3109/10641955.2013.858745
Beneventi, F., Locatelli, E., De Amici, M., Cavagnoli, C., Bellingeri, C., De Maggio, I., Ruspini, B., & Spinillo, A. (2020). Maternal and fetal Leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine, 33(23), 3942–3948. https://doi.org/10.1080/14767058.2019.1593359
Bilano, V. L., Ota, E., Ganchimeg, T., Mori, R., & Souza, J. P. (2014). Risk Factors of Pre- Eclampsia/Eclampsia and Its Adverse Outcomes in Low- and Middle-Income Countries: A WHO Secondary Analysis. PLoS ONE, 9(3), e91198. https://doi.org/10.1371/journal.pone.0091198
Chappell, L. C., Cluver, C. A., Kingdom, J., & Tong, S. (2021). Pre-eclampsia. The Lancet, 398(10297), 341–354. https://doi.org/10.1016/S0140-6736(20)32335-7
Cormick, G., Betrán, A. P., Ciapponi, A., Hall, D. R., & Hofmeyr, G. J. (2016). Inter-pregnancy interval and risk of recurrent pre-eclampsia: Systematic review and meta-analysis. Reproductive Health, 13(1), 83. https://doi.org/10.1186/s12978-016-0197-x
Cunningham, F. G. (Ed.). (2018). Williams obstetrics (25th edition). McGraw-Hill.
Duckitt, K., & Harrington, D. (2005). Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ, 330(7491), 565. https://doi.org/10.1136/bmj.38380.674340.E0
Elgari, M. M., Khabour, O. F., & Alhag, S. M. (2019). Correlations between changes in hematological indices of mothers with preeclampsia and umbilical cord blood of newborns. Clinical and Experimental Hypertension, 41(1), 58–61. https://doi.org/10.1080/10641963.2018.1441861
Harutyunyan, A., Armenian, H., & Petrosyan, V. (2013). Interbirth interval and history of previous preeclampsia among multiparous women: A case-control study. European Journal of Public Health, 23(suppl_1). https://doi.org/10.1093/eurpub/ckt123.156
Irhamna, R., Pramesthi, X. A., Nasrullah, Y. A., & Wartiningsih, M. (2019). Prevent Mortality Rates of Pregnant Women in Preeclampsia Condition Based on Characteristics Analysis (Case Study in RSUD Dr. Mohammad Soewandhie Surabaya 2017). 4.
Jain, S., Sharma, P., Kulshreshtha, S., Mohan, G., & Singh, S. (2010). The Role of Calcium, Magnesium, and Zinc in Pre-Eclampsia. Biological Trace Element Research, 133(2), 162– 170. https://doi.org/10.1007/s12011-009-8423-9
Kemenkes RI. (2021). Profil Kesehatan Indonesia Tahun 2020. Kementerian Kesehatan RI. https://www.kemkes.go.id/downloads/resources/download/pusdatin/profil-kesehatan- indonesia/Profil-Kesehatan-Indonesia-Tahun-2020.pdf
Lisonkova, S., Sabr, Y., Mayer, C., Young, C., Skoll, A., & Joseph, K. S. (2014). Maternal Morbidity Associated With Early-Onset and Late-Onset Preeclampsia. Obstetrics & Gynecology, 124(4), 771–781. https://doi.org/10.1097/AOG.0000000000000472
Luo, Z.-C., An, N., Xu, H.-R., Larante, A., Audibert, F., & Fraser, W. D. (2007). The effects and mechanisms of primiparity on the risk of pre-eclampsia: A systematic review. Paediatric and Perinatal Epidemiology, 21(s1), 36–45. https://doi.org/10.1111/j.1365- 3016.2007.00836.x
Mutiara, B., Amirus, K., Aryastuti, N., Wulandari, R., & Sudirahayu, I. (2018). Analisis Faktor Risiko yang Mempengaruhi Tekanan Darah dan Protein Urine pada Ibu dengan Preeklamsia di RSUD dr. H. Abdul Meoloek Provinsi Lampung 2017. Jurnal Kesmas (Kesehatan Masyarakat) Khatulistiwa, 4(3), 48. https://doi.org/10.29406/jkmk.v5i2.1567
Nilsson, E., Salonen Ros, H., Cnattingius, S., & Lichtenstein, P. (2004). The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: A family study. BJOG: An International Journal of Obstetrics and Gynaecology, 111(3), 200–206. https://doi.org/10.1111/j.1471-0528.2004.00042x.x
Njoroge, S., Kuriloff, M., Mueller, A., Lopes Perdigao, J., Dhir, R., & Rana, S. (2021). The interval between births and the risk of recurrent preeclampsia among predominantly high risk women in urban tertiary care center. Pregnancy Hypertension, 25, 7–11. https://doi.org/10.1016/j.preghy.2021.05.009
Peterson, E., Craigo, S., & House, M. (2010). Risk Factors for Postpartum Antihypertensive Medication Requirement in Severe Preeclampsia. Hypertension in Pregnancy, 29(3), 350– 356. https://doi.org/10.3109/10641950902968700
Rafida, M., Mochtar, N. M., Artiningtyas, N. D., & Anas, M. (2021). Relationship of Age, Body Mass Index, and Gravida in Pregnant Women With Preeclampsia in Muhammadiyah Hospital Surabaya: 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020), Yogyakarta, Indonesia. https://doi.org/10.2991/ahsr.k.210115.008
Rao, J., Fan, D., Ma, H., Lin, D., Zhang, H., Zhou, Z., Li, P., Chen, G., Lu, D., Liu, Y., Wu, Z.,
He, J., Liu, X., Peng, B., Guo, X., & Liu, Z. (2022). Is there an optimal inter-delivery interval in women who underwent trial of labor after cesarean delivery (TOLAC)? Reproductive Health, 19(1), 14. https://doi.org/10.1186/s12978-021-01319-0
Robillard, P.-Y., Dekker, G., Boukerrou, M., Boumahni, B., Hulsey, T., & Scioscia, M. (2020). Gestational weight gain and rate of late-onset preeclampsia: A retrospective analysis on 57 000 singleton pregnancies in Reunion Island. BMJ Open, 10(7), e036549. https://doi.org/10.1136/bmjopen-2019-036549
Shan, D., Qiu, P.-Y., Wu, Y.-X., Chen, Q., Li, A.-L., Ramadoss, S., Wang, R.-R., & Hu, Y.-Y.
(2018). Pregnancy Outcomes in Women of Advanced Maternal Age: A Retrospective Cohort Study from China. Scientific Reports, 8(1), 12239. https://doi.org/10.1038/s41598- 018-29889-3
Sheen, J.-J., Huang, Y., Andrikopoulou, M., Wright, J. D., Goffman, D., D’Alton, M. E., & Friedman, A. M. (2020). Maternal Age and Preeclampsia Outcomes during Delivery Hospitalizations. American Journal of Perinatology, 37(01), 044–052. https://doi.org/10.1055/s-0039-1694794
Sibai, B. M. (2012). Etiology and management of postpartum hypertension-preeclampsia. American Journal of Obstetrics and Gynecology, 206(6), 470–475. https://doi.org/10.1016/j.ajog.2011.09.002
Stulberg, D. B., Jackson, R. A., & Freedman, L. R. (2016). Referrals for Services Prohibited In Catholic Health Care Facilities: Referrals in Catholic Healthcare Facilities. Perspectives on Sexual and Reproductive Health, 48(3), 111–117. https://doi.org/10.1363/48e10216
Tinta, Y., Polopadang, V., Rais, Muh. K., & . S. (2020). Related Factors to Preeclampsia Incidence in Pregnant Women at Lasinrang Regional Hospital Pinrang. South Asian Research Journal of Nursing and Healthcare, 02(01), 12–16. https://doi.org/10.36346/sarjnhc.2020.v02i01.002
Tyas, B. D., Lestari, P., & Aldika Akbar, M. I. (2019). Maternal Perinatal Outcomes Related to Advanced Maternal Age in Preeclampsia Pregnant Women. Journal of Family & Reproductive Health, 13(4), 191–200.
Wang, Y., Wu, N., & Shen, H. (2021). A Review of Research Progress of Pregnancy with Twins with Preeclampsia. Risk Management and Healthcare Policy, Volume 14, 1999–2010. https://doi.org/10.2147/RMHP.S304040
Weissgerber, T. L., & Mudd, L. M. (2015). Preeclampsia and Diabetes. Current Diabetes Reports, 15(3), 9. https://doi.org/10.1007/s11892-015-0579-4
Wilkerson, R. G., & Ogunbodede, A. C. (2019). Hypertensive Disorders of Pregnancy. Emergency Medicine Clinics of North America, 37(2), 301–316. https://doi.org/10.1016/j.emc.2019.01.008
World Health Organization. (2010, May). A healthy lifestyle—WHO recommendations. https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who- recommendations
World Health Organization. (2021). Digital adaptation kit for antenatal care: Operational requirements for implementing WHO recommendations in digital systems. World Health Organization. https://apps.who.int/iris/handle/10665/339745
Wu, C.-T., Kuo, C.-F., Lin, C.-P., Huang, Y.-T., Chen, S.-W., Wu, H.-M., & Chu, P.-H. (2021).
Association of family history with incidence and gestational hypertension outcomes of preeclampsia. International Journal of Cardiology Hypertension, 9, 100084. https://doi.org/10.1016/j.ijchy.2021.100084
Wu, P., Haththotuwa, R., Kwok, C. S., Babu, A., Kotronias, R. A., Rushton, C., Zaman, A., Fryer,
A. A., Kadam, U., Chew-Graham, C. A., & Mamas, M. A. (2017). Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circulation: Cardiovascular Quality and Outcomes, 10(2), e003497. https://doi.org/10.1161/CIRCOUTCOMES.116.003497
Yang, Y., & Wu, N. (2022). Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors. Frontiers in Cardiovascular Medicine, 9, 831297. https://doi.org/10.3389/fcvm.2022.831297